Results 201 to 210 of about 21,457 (213)

Memory B Cells and Response to Abatacept in Rheumatoid Arthritis

Clinical Reviews in Allergy and Immunology, 2017
Guillermo Carvajal Alegria, Valérie Devauchelle-Pensec, Christophe Jamin   +2 more
exaly  

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan

Rheumatology, 2015
Tsutomu Takeuchi, Masaya Mukai, Koichi Amano   +2 more
exaly  

Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept

Modern Rheumatology, 2019
Takeshi Mochizuki, Koichiro Yano, Ken Okazaki   +2 more
exaly  

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study

Rheumatology, 2019
Francois Montastruc, Christel Renoux, Teresa A Simon   +2 more
exaly  

Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

Modern Rheumatology, 2013
Tsutomu Takeuchi
exaly  

Population Pharmacokinetics and Exposure‐Response Relationship of Intravenous and Subcutaneous Abatacept in Patients With Rheumatoid Arthritis

Journal of Clinical Pharmacology, 2019
Xiaohui Li
exaly  

Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis

Clinical Rheumatology, 2010
Michael Schiff, Louis Bessette
exaly  

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)

Clinical Rheumatology, 2016
Florenzo Iannone, María Victoria Hernández, Helena Canhão   +2 more
exaly  

Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis

Drugs, 2013
exaly  

Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis

Expert Opinion on Biological Therapy, 2005
Larry W Moreland
exaly